2 Patents
- US122698892025Human Antibodies to the Human Glucagon Receptor (HGCGR) and Methods of Use Thereof to Lower Blood Glucose or Ketone Levels
REGENERON PHARMACEUTICALS, Inc.
0 cites - US117084162023Methods of Treating Severe Insulin Resistance by Interfering with Glucagon Receptor Signaling
REGENERON PHARMACEUTICALS, Inc.
0 cites